Seeking a Bottom in Choppy Markets? Two Long-Term Picks with “Anti-Fragile” Qualities Life Science, Technology
The Obesity Drug War Goes Oral: Why Eli Lilly’s Orforglipron Could Steal the Spotlight from Novo Life Science
Novo Nordisk’s Price Cuts and R&D Progress Go Hand in Hand, GLP-1 Drug Prices Reduced by Up to 50% Life Science
$70 Billion and Counting: The 5 US Dividend Giants That Keep on Giving Energy, Financial Service, Life Science, Technology
This Cathie Wood-Favored Gene-Editing Stock Is Up 47% This Year. Is It Poised to Take Off? Life Science
Clinical Data Optimism Combined with Analyst Recommendation Drives Shattuck Labs Shares Up 53% This Week Life Science
A Dividend Yield of Up to 4% and 48 Consecutive Years of Increases, Watch These Two Healthcare Giants Life Science
